Clinical Trial Update: Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety and tolerability of rilonacept in patients with Muckle-Wells Syndrome and Schnitzler Syndrome; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muckle-wells Syndrome
• Schnitzler Syndrome

Drugs mentioned

• Arcalyst (rilonacept)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Muckle-Wells Syndrome, Schnitzler Syndrome | Phase 2 | Status: COMPLETED